期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Endokrynologia Polska LetPub Score 4.7
50 ratings
Rate
Reputation 5.6 Influence 3.6 Speed 6.9 | ||||||||||||||||||||
期刊簡稱 | ENDOKRYNOL POL | ||||||||||||||||||||
ISSN | 0423-104X | ||||||||||||||||||||
h-index | 24 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 10.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://journals.viamedica.pl/endokrynologia_polska | ||||||||||||||||||||
在線稿件提交 | https://journals.viamedica.pl/endokrynologia_polska/login?source=%2Fendokrynologia_polska%2Fuser%2FnewSubmission | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Via Medica | ||||||||||||||||||||
主題領域 | ENDOCRINOLOGY & METABOLISM | ||||||||||||||||||||
出版國/地區 | POLAND | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1950 | ||||||||||||||||||||
每年文章數 | 77每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.55% | ||||||||||||||||||||
OA Related Info | APC: Yes( EUR615; ) APC waiver:No Other charges: No Keywords: therapy、hormones、secretion、endocrynology、metabolism、diabetes Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0423-104X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Endokrynologia Polska] 的評論 | 撰寫評論 |
作者: 努力啊大弘新 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-14 15:07:58 評論於 Hello, I received an email titled "Reassessment after essential revision", may I ask if it is a major revision or a minor one?(0) 讚! | 努力啊大弘新 |
作者: 努力啊大弘新 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-14 10:00:16 評論於 Hello, is "rework" referring to major or minor repairs? What does "Reassessment after essential revision" mean?(0) 讚! | 努力啊大弘新 |
作者: 破戒宇彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-12 21:25:19 評論於 Layout fee 5000 yuan(0) 讚! | 破戒宇彤 |
作者: 破戒宇彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-30 19:42:26 評論於 Review speed: 1.0 | Submission success rate: 75.0 Focus research areas: Retina; Diabetic retinopathy Experience sharing in diabetic retinopathy: Submitted on July 1, 2023, reviewed on July 3, and notified for revisions on July 31(0) 讚! | 破戒宇彤 |
作者: 破戒宇彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-27 19:06:13 評論於 Review Speed: 1.0 | Submission Hit Rate: 75.0 Emphasized Research Direction: Retina; Diabetic Retinopathy; Clinical Experience Sharing: Submitted on July 1, 2023, notified of revisions on July 31, with minimal changes made to the content, responded to reviewers' questions, revised on August 10, accepted on August 16, proof on October 11, published on October 23(0) 讚! | 破戒宇彤 |
作者: 努力啊大弘新 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-17 22:24:11 評論於 Is "in review" for internal audit or external audit? How many stages does the entire review process go through?(0) 讚! | 努力啊大弘新 |
作者: 玄清 領域: 医学 審稿時間: 3.0 month(s) 結果: 拒稿 撰寫評論 |
2023-07-11 15:20:47 評論於 At the beginning of the year, after submitting, it took about half a month for it to show "sent for external review". The review took about 3 months, but it was directly rejected without any reason provided! I sent an email to the editorial department, asking to see the review comments in order to make revisions, but I haven't received any response.(0) 讚! | 玄清 |
作者: 一只振海呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-09 10:33:57 評論於 How much is the payment?(0) 讚! | 一只振海呀 |
作者: 素伟三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-24 20:16:04 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted at the end of September 2022, received acceptance after two months of first review without major revisions. Acceptance rate among Chinese authors is okay, and rejections are also quite fast. Worth a try(0) 讚! | 素伟三岁啦 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:56:24 評論於 The novelty of an article may be assessed through keyword searches(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:23:35 評論於 The main task of the introduction is to outline the basic content and structure of the whole article for the author. First, it is necessary to summarize the past and current situations in the field comprehensively, especially the latest advances and references to classic literature from the past. Analyze the limitations of past research and clarify the innovative points of your own research(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 08:13:02 評論於 How do reviewers use keywords to review?(0) 讚! | 陶宜三岁啦 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 08:47:09 評論於 How to write an introduction?(0) 讚! | 北国博达 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us